118 related articles for article (PubMed ID: 2423797)
21. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
Luomanmäki K; Hartikainen M
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
[TBL] [Abstract][Full Text] [Related]
22. Antihypertensive effects of indoramin and prazosin in combination with hydrochlorothiazide.
Solomon R
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S56-62. PubMed ID: 2423799
[TBL] [Abstract][Full Text] [Related]
23. Age dependence of therapy result and risk in the treatment of arterial hypertension?
Höffler D; Morgenstern HO
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
[TBL] [Abstract][Full Text] [Related]
25. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR;
Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700
[TBL] [Abstract][Full Text] [Related]
26. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
27. Comparison of indoramin and methyldopa in hypertension.
Rosendorff C
S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
[TBL] [Abstract][Full Text] [Related]
28. Step-one antihypertensive therapy: a comparison of a centrally acting agent and a diuretic.
McCarron DA
J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S853-8. PubMed ID: 6084139
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.
Naritomi H; Fujita T; Ito S; Ogihara T; Shimada K; Shimamoto K; Tanaka H; Yoshiike N
Hypertens Res; 2008 Feb; 31(2):295-304. PubMed ID: 18360050
[TBL] [Abstract][Full Text] [Related]
30. Double blind evaluation of indoramin and methyldopa in thiazide treated hypertensive patients.
Yajnik VH; Patel SC
Indian Heart J; 1978; 30(1):51-6. PubMed ID: 359454
[No Abstract] [Full Text] [Related]
31. Blood pressure control in patients initiating antihypertensive therapy.
Weycker D; Edelsberg J; Vincze G; Levy DG; Kartashov A; Oster G
Ann Pharmacother; 2008 Feb; 42(2):169-76. PubMed ID: 18182472
[TBL] [Abstract][Full Text] [Related]
32. Pulse pressure monitoring of open antihypertensive therapy.
Safar ME; Vaisse B; Blacher J; Rudnichi A; Mourad JJ
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1088-94. PubMed ID: 15607613
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of mild and moderate hypertension with the use of captopril alone or combined with hydrochlorothiazide. A multicenter study].
Nascimento LO; Lion R; Lion MF; Pesquisadores E
Arq Bras Cardiol; 1989 Sep; 53(3):177-83. PubMed ID: 2698133
[TBL] [Abstract][Full Text] [Related]
34. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the antihypertensive effects of betaxolol and chlorthalidone as monotherapy and in combination.
Burris JF; Davidov ME; Jenkins P; Rofman B; Ginsberg D; Rosenbaum R; Ryan JR; Jain AK; Mroczek WJ
Arch Intern Med; 1989 Nov; 149(11):2437-41. PubMed ID: 2684073
[TBL] [Abstract][Full Text] [Related]
36. Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension.
Bennett JM; Weich DJ; Schoeman HS
S Afr Med J; 1988 Dec; 74(12):619-21. PubMed ID: 3061032
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
Overlack A; Stumpe KO
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798
[TBL] [Abstract][Full Text] [Related]
38. Indoramin as an antihypertensive agent in the treatment of essential hypertension. A multicentre trial.
Bednarek MR; Schoeman HS
S Afr Med J; 1983 Mar; 63(11):398-400. PubMed ID: 6338603
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
Marshall AJ; Kettle MA; Barritt DW
Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
[TBL] [Abstract][Full Text] [Related]
40. [Indoramin, a drug with prevalent antihypertensive activity: experimental study].
Marmo E; Rossi F; Caputi AP; Lampa E; Petrarca R; Ottavo R
Clin Ter; 1979 Feb; 88(3):233-62. PubMed ID: 445975
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
